pyrrolidine dithiocarbamate has been researched along with Kidney Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, SS; Feng, YJ; Wang, XH; Ye, DQ; Zhai, JX; Zhang, ZX; Zou, LW | 1 |
Cheng, X; He, D; Li, X; Luo, Y; Xue, Y; Zhang, L | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Kidney Failure
Article | Year |
---|---|
PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Antioxidants; Chemokine CCL2; Female; Gene Expression; Gene Expression Regulation; Glomerulonephritis, Membranoproliferative; Kidney; Lipopolysaccharides; Lupus Erythematosus, Systemic; MAP Kinase Signaling System; Mice; Mice, Inbred MRL lpr; Mitogen-Activated Protein Kinases; Phosphorylation; Proteinuria; Pyrrolidines; Renal Insufficiency; Thiocarbamates; Transcription Factor RelA | 2012 |
Pyrrolidine dithiocarbamate attenuate shock wave induced MDCK cells injury via inhibiting nuclear factor-kappa B activation.
Topics: Animals; Antioxidants; Blotting, Western; Cell Line; Cyclooxygenase 2; Dogs; Fluorescent Antibody Technique; I-kappa B Proteins; Lithotripsy; NF-kappa B; Nitric Oxide Synthase Type II; Pyrrolidines; Renal Insufficiency; Thiocarbamates; Transcription Factor RelA | 2007 |